8. How Lepodisiran Works at the Genetic Level

Lepodisiran’s innovation lies in its use of RNA interference to target the LPA gene directly.
By “silencing” this gene, the drug blocks the liver’s ability to produce Lp(a) particles, dramatically reducing their presence in the bloodstream.
This method is part of a new wave of gene-targeted therapies revolutionizing cardiovascular treatment.
To explore the science behind this, see
Nature Reviews Cardiology.